SSY Group Limited (HKG:2005)

Market Cap	8.61B
Revenue (ttm)	5.77B
Net Income (ttm)	1.06B
Shares Out	2.95B
EPS (ttm)	0.36
PE Ratio	8.15
Forward PE	7.36
Dividend	0.18 (6.23%)
Ex-Dividend Date	May 20, 2025

Volume	30,164,000
Average Volume	17,234,784
Open	2.800
Previous Close	2.810
Day's Range	2.800 - 2.980
52-Week Range	2.580 - 4.970
Beta	0.64
RSI	41.70
Earnings Date	Aug 28, 2025

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 6,146
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2024, SSY Group's revenue was 5.77 billion, a decrease of -10.67% compared to the previous year's 6.46 billion. Earnings were 1.06 billion, a decrease of -19.53%.